These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 480157)

  • 1. Binding of mono- and bis-N-substituted benzoquinolinium halides to butyrylcholinesterase: fluorescence measurements.
    Chen WS; Cocolas GH; Cavallito CJ
    J Pharm Sci; 1979 Aug; 68(8):1025-27. PubMed ID: 480157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent reversible anticholinesterase agents. Bis- and mono-N-substituted benzoquinolinium halides.
    Chen WS; Cocolas GH; Cavallito CJ; Chai KJ
    J Med Chem; 1977 Dec; 20(12):1617-23. PubMed ID: 592327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Accelerating effect of heterocyclic quaternary ammonium salts on neutral ester hydrolysis by acetylcholinesterase and butyrylcholinesterase (author's transl)].
    Desire B; Saint-Andre S
    Biochim Biophys Acta; 1981 Jun; 659(2):267-82. PubMed ID: 7260096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interaction of spin-labeled methacyne analog with butyrylcholinesterase].
    Dorokhov KE; Grigorian GL; Kardanov NA; Zhdanov RI; Trifonova SA
    Biofizika; 1985; 30(1):23-6. PubMed ID: 2983779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of butyrylcholinesterase by organophosphorus compounds: a quantitative structure-activity analysis.
    Barbato F; Cappello B; Silipo C; Vittoria A
    Farmaco Sci; 1982 Aug; 37(8):519-36. PubMed ID: 7128809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticholinesterase properties of benzo(f)quinolinium derivatives].
    Kuleshov VI; Kozlov NS; Libman NM; Kosmacheva IM; Zhikhareva OD
    Biokhimiia; 1981 Oct; 46(10):1764-7. PubMed ID: 7306595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential binding of phenothiazine urea derivatives to wild-type human cholinesterases and butyrylcholinesterase mutants.
    Darvesh S; Pottie IR; Darvesh KV; McDonald RS; Walsh R; Conrad S; Penwell A; Mataija D; Martin E
    Bioorg Med Chem; 2010 Mar; 18(6):2232-2244. PubMed ID: 20181484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Inverse' substrates for butyrylcholinesterase.
    Nozawa M; Tanizawa K; Kanaoka Y
    Biochim Biophys Acta; 1980 Feb; 611(2):314-22. PubMed ID: 7357012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, in vitro evaluation and molecular modelling of pyridinium-quinolinium/isoquinolinium non-symmetrical bisquaternary cholinesterase inhibitors.
    Komloova M; Horova A; Hrabinova M; Jun D; Dolezal M; Vinsova J; Kuca K; Musilek K
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6663-6. PubMed ID: 24220173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors.
    Radić Z; Pickering NA; Vellom DC; Camp S; Taylor P
    Biochemistry; 1993 Nov; 32(45):12074-84. PubMed ID: 8218285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
    Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
    Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanistic model for butyrylcholinesterase.
    Eriksson H; Augustinsson KB
    Biochim Biophys Acta; 1979 Mar; 567(1):161-73. PubMed ID: 454620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Binding of reversible spin-labeled inhibitors with an butyrylcholinesterase active center].
    Dorokhov KE; Grigorian GL
    Biofizika; 1986; 31(5):746-51. PubMed ID: 3022829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reactivation of phosphorylated cholinesterase immobilized in a gelatin membrane].
    Kugusheva LI; Nikol'skaia EB
    Ukr Biokhim Zh (1978); 1990; 62(2):93-6. PubMed ID: 2368191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adamantane-substituted guanylhydrazones: novel inhibitors of butyrylcholinesterase.
    Sekutor M; Mlinarić-Majerski K; Hrenar T; Tomić S; Primožič I
    Bioorg Chem; 2012; 41-42():28-34. PubMed ID: 22336689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Basic substituted pyrrolidine-2,5-dione. 4. The inhibitory action of optically active basic substituted pyrrolidine-2,5-diones on butyrylcholinesterase].
    Knabe J; Büch HP; Konrad H
    Arch Pharm (Weinheim); 1986 Jul; 319(7):661-3. PubMed ID: 3767620
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment.
    Komloova M; Musilek K; Horova A; Holas O; Dohnal V; Gunn-Moore F; Kuca K
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2505-9. PubMed ID: 21397501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benzimidazolium derivatives with delocalized charge in the cation group as reversible inhibitors of cholinesterases of different origin].
    Rozengart EV; Girshovich MZ; Basova NE
    Dokl Akad Nauk; 1997 Jul; 355(1):123-5. PubMed ID: 9333408
    [No Abstract]   [Full Text] [Related]  

  • 19. The interaction of amiloride with acetylcholinesterase and butyrylcholinesterase.
    Zemach L; Segal D; Shalitin Y
    FEBS Lett; 1990 Apr; 263(1):166-8. PubMed ID: 2332047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the mid-gorge of cholinesterases with spacer-modified bivalent quinazolinimines leads to highly potent and selective butyrylcholinesterase inhibitors.
    Chen X; Tikhonova IG; Decker M
    Bioorg Med Chem; 2011 Feb; 19(3):1222-35. PubMed ID: 21232964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.